Submitted by Anonymous (not verified) on 14 August 2023 - 14:50
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Osteoporosis, Date of authorisation: 09/12/2019, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Osteoporosis, Date of authorisation: 09/12/2019, Revision: 4, Status: Authorised